MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2020

    Frequency of Wearing-Off Symptoms in Parkinson’s disease Fluctuators: An on/off evaluation

    K. Perepezko, J. Hinkle, K. Mills, G. Pontone (Baltimore, MD, USA)

    Objective: To determine if the frequency of wearing-off symptoms in Parkinson’s disease (PD) patients who report fluctuations differs from patients without fluctuations. Background: Wearing-off, the…
  • MDS Virtual Congress 2020

    Prevalence, impact, and factors associated with excessive buccal saliva in the COPARK database

    S. Perez-Lloret, L. Negre-Pages, P. Damier, A. Delval, P. Derkinderen, A. Destée, M. Fabbri, W. Meissner, A. Rachdi, F. Tison, O. Rascol (Buenos Aires, Argentina)

    Objective: To describe the prevalence of sialorrhea and drooling in Parkinson’s Disease (PD) patients of the COPARK study, to find factors associated to these conditions,…
  • MDS Virtual Congress 2020

    Temporal characterization of motor, gastrointestinal, and behavioral symptoms in a SNCA A53T transgenic mouse model of Parkinson’s disease

    N. Radisavljevic, M. Cirstea, K. Bauer, B. Finlay (Vancouver, BC, Canada)

    Objective: While multiple animal models of Parkinson’s disease (PD) have been developed with varying applicability to different aspects of the disorder, no single model effectively…
  • MDS Virtual Congress 2020

    Sleep disturbances in Vascular Parkinsonism (VP) and Parkinson’s Disease (PD) patients in early stages

    R. Raimundo, M. Mendes, R. Jesus, C. Azoia, A. Marques, A. Almeida, A. Velon (Vila Real, Portugal)

    Objective: Compare sleep disturbances between VP and PD patients. Background: Sleep disorders in PD patients are well recognized, ranging from nocturnal symptoms such as insomnia,…
  • MDS Virtual Congress 2020

    Early life stress offers a window into the relationship between depression and Parkinson’s disease: A 60-week study after maternal separation in rats

    C. Ren, K.J He, Y.T Zhang, J.B Zhang, F. Wang, C.F Liu (Suzhou, China)

    Objective: The aim of this study was to examine the relationship between depression and Parkinson's disease (PD) using the rat model of maternal separation (MS).…
  • MDS Virtual Congress 2020

    Apomorphine improves pulmonary function in parkinsonian patients

    I. Reuter (Giessen, Germany)

    Objective: Aim of the study;  to investigate if apomorphine might  facilitate weaning from mechanical ventilation in parkinsonian patients. Background: Apomorphine is an effective treatment for PD…
  • MDS Virtual Congress 2020

    Association between essential tremor, constipation, and the risk of developing Parkinson’s disease

    C. Reynolds, M. Gupta, M. Sandulescu (Danville, PA, USA)

    Objective: To evaluate the association between constipation and the risk of Parkinson’s disease (PD) in patients with a prior history of essential tremor (ET). Background:…
  • MDS Virtual Congress 2020

    RBD and autonomic dysfunction in newly diagnosed Parkinson’s disease patients

    G.M Riboldi, L. Pan, K. dePaiva Lopes, K. Watkins, T. Raj, U. Kang (New York, NY, USA)

    Objective: To determine whether newly diagnosed Parkinson’s disease (PD) patients with REM sleep behavior disorder (RBD) are more likely to have symptoms of autonomic dysfunction.…
  • MDS Virtual Congress 2020

    Prevalence of non-motor symptoms in Parkinson’s disease using the Movement Disorder Society-Non-Motor Rating Scale (MDS-NMS) and comparable scales

    C. Rodriguez-Blazquez, A. Schrag, D. Weintraub, A. Rizos, K.R Chaudhuri, P. Martinez-Martin (Madrid, Spain)

    Objective: To analyze the frequency and differences in distribution by sex and disease severity of non-motor symptoms (NMS) in patients with Parkinson’s disease (PD) using…
  • MDS Virtual Congress 2020

    The non-declaration of musculoskeletal pain in Parkinson’s disease in patient-related outcome measures –The King’s experience

    K. Rukavina, M. Krbot Skoric, C. Borley, L. Batzu, A. Rizos, D. van Wamelen, K. Ray Chaudhuri (London, United Kingdom)

    Objective: To determine the usefulness of patient related outcome (PRO) measures in highlighting non-declaration of pain, a challenging non-motor symptom (NMS) of Parkinson’s disease (PD).…
  • « Previous Page
  • 1
  • …
  • 1112
  • 1113
  • 1114
  • 1115
  • 1116
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley